Drugs in MeSH Category Reverse Transcriptase Inhibitors
✉ Email this page to a colleague
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead | EMTRIVA | emtricitabine | CAPSULE;ORAL | 021500-001 | Jul 2, 2003 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
| Annora | LAMIVUDINE | lamivudine | TABLET;ORAL | 211306-001 | Mar 21, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
| Mylan Labs Ltd | STAVUDINE | stavudine | CAPSULE;ORAL | 078775-002 | Jan 5, 2009 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Mylan | NEVIRAPINE | nevirapine | TABLET, EXTENDED RELEASE;ORAL | 206271-001 | Nov 9, 2015 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Bristol-myers Squibb | ZERIT | stavudine | CAPSULE;ORAL | 020412-003 | Jun 24, 1994 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Aurobindo Pharma | DIDANOSINE | didanosine | CAPSULE, DELAYED REL PELLETS;ORAL | 090094-002 | Sep 24, 2008 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
